First Funders
Shahram Seyedin-Noor isn’t a physician. Nor is he a chemist. And he’s not a software engineer, either. But you wouldn’t know by the way he commands all of these spaces to invest in some truly cutting edge bio technology like genomics, therapeutics, and diagnostics just to name a few. He’s been at this for almost 20 years, with almost half of that time spent as the founder and managing partner of Civilization Ventures, where he writes $100k – $5m checks into pre-seed and seed biotech companies. He focuses on the spaces in healthcare that don’t always get their due, such as diagnostics and longevity. In this episode, Shahram takes us through how he’s been able to break down barriers as an outsider, why diagnostics needs a rebrand, and what he looks for in AI-native founders. Check size: $100k - $5m Highlights: * Shahram’s winding path to his current role has established him as an outsider who’s able to quickly and easily obtain insider knowledge for almost any domain. * Civilization Ventures started with just $1 million, but to date its had 17 exits and 3 IPOs including Rocket Pharma [https://rocketpharma.com/], Omada Health [https://www.omadahealth.com/], and BillionToOne [https://www.billiontoone.com/], with an ever-growing portfolio of companies in the biotech space including companies like Aspect Biosystems [https://www.aspectbiosystems.com/], Curai Health [https://curaihealth.com/], and Foresight Diagnostics [https://foresight-dx.com/]. * Diagnostics has been unfairly maligned, but it shouldn’t be considered a dirty word within the industry. * Incremental medicine has its place, but it’s curative treatments that get Shahram most excited. * These days, Shahram isn’t just looking for AI companies, he’s looking for AI-native founders. Chapters: 00:00 – From Immigrant Kid to Venture Capitalist 08:30 – Building a VC Fund Like a Startup 15:30 – The Contrarian Thesis: Betting on First-Time Founders 20:00 – Why Diagnostics Became the Opportunity Everyone Else Ignored 24:45 – The Three Investment Pillars 30:30 – AI’s Impact on Biotech Investing 38:30 – Contrarian Investing vs Following Hype 41:00 – Beyond Returns: Building Civilization
24 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de First Funders!